NYSE American · Shell Companies · USD

Legato Merger Corp. III (LEGT) Stock Analysis

Legato Merger Corp. III (LEGT) is a Shell Companies stock listed on NYSE American and quoted in US Dollar.

LEGT

$9.52

−$1.57 (−14.16%)

Last trade June 9, 2026

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare LEGT with… →

LEGT Key Statistics

As of Jun 9, 2026

Trading

Open: $10.30
Previous Close: $11.09
Day's Range: 8.52–10.30
52-Week Range: 10.57–11.94
Volume: 78.10K
Beta: −0.03

Valuation

Market Cap: $250.26M
P/E Ratio: 38.24
EPS (ttm): 0.29

Financials (FY)

Profit margin: 0.00%
1-Year Return: −10.36%

Dividend and dates

Avg Volume: 105.23K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

LEGT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−0.05%+5.73%−12.50%

2024*20252026*

Year	Return
2026 (partial year)	−12.50%
2025	+5.73%
2024 (partial year)	−0.05%

As of June 9, 2026.

LEGT Valuation vs Shell Companies Median

Median of 587 stocks

Metric	LEGT	Shell Companies median	vs median
P/E	38.24	45.20	15% below
Profit margin	0.00%	0.00%	0.0 pts above

Medians across 587 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Legato Merger Corp. III (LEGT) is capitalised at $250.26M on the latest close. The company sits in the Financial Services sector, in the Shell Companies industry.

The 52-week range on file runs from $10.57 to $11.94. LEGT last closed at $9.52 on June 9, 2026. That is −$1.57 (−14.16%) against the previous close.

Financial Health

Profit margin runs at 0%. Earnings per share on a trailing basis come to 0.29.

Valuation Assessment

The trailing P/E ratio stands at 38.24. That is 15.4% below the Shell Companies median of 45.2. The medians here are taken across 587 Shell Companies companies that report the metric.

Beta against the wider market is reported at −0.03. Daily returns over the trailing 1 year annualize to a volatility of 16.09%. Over the trailing twelve months the price has returned −10.36%.

Growth & Income

No dividend is on file for LEGT.

2026 is still running; the price is −12.50% year to date. The record holds one complete calendar year, 2025, which returned +5.73%.

Peer Comparison

Legato Merger Corp. III (LEGT) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Legato Merger Corp. III	LEGT	$250.26M	38.2
Churchill Capital Corp XI	CCXI	$746.38M	—
Churchill Capital Corp X	CCCX	$711.00M	—
Drugs Made In America Acquisition II Corp.	DMII	$647.83M	35.1

The Shell Companies industry average P/E ratio is 45.2x. Legato Merger Corp. III trades at a P/E of 38.2.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of June 9, 2026.

Related Shell Companies Stocks

CCXI

Churchill Capital Corp XI

$746.38M

CCCX

Churchill Capital Corp X

$711.00M

DMII

Drugs Made In America Acquisition II Corp.

$647.83M

BCSS

Bain Capital GSS Investment Corp.

$602.40M

EVAC

EQV Ventures Acquisition Corp. II

$602.01M

CXII

Churchill Capital Corp XII

$594.94M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About Legato Merger Corp. III

Legato Merger Corp. III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other related business combination with one or more target businesses or entities. The company was incorporated in 2023 and is based in New York, New York.

Visit website →